New publication: TEFM variants impair mitochondrial transcription causing childhood-onset neurological disease

Lochmüller Lab Members Published as Authors in Nature Communications Study

We are excited to share that the study “TEFM variants impair mitochondrial transcription causing childhood-onset neurological disease”, containing contributions from several lab members, was published in the journal Nature Communications on February 23, 2023. Postdoc members Dr. Kiran Polavarapu and Dr. Emily O’Connor, along with Dr. Hanns Lochmüller, are all authors on the paper.

This international, multi-center study establishes TEFM as a  candidatemitochondrial disease gene. Recessive or biallelic TEFM mutations were identified in seven patients from five unrelated families with a wide range of infantile or childhood-onset neurological and neuromuscular symptoms. A combination of clinical phenotyping and muscle pathology along with in silico protein analysis, and mitochondrial function investigations helped in establishing the causal effect of TEFM in these patients. Findings from patients were further supported by zebrafish studies, including movement and neuromuscular analysis1.

These data suggest the consideration of TEFM in the genetic diagnostic workup of patients that present with neonatal or childhood onset mitochondrial encephalomyopathy with  fatigable muscle weakness, epilepsy and variable degree of intellectual disability, and some of these patients with neuromuscular junction defect can benefit from early therapeutic intervention.

Read the Full Publication

The article is open access, and available to read here: https://pubmed.ncbi.nlm.nih.gov/36823193/.

Reference

  1. Van Haute, L., O'Connor, E., Díaz-Maldonado, H., Munro, B., Polavarapu, K., Hock, D. H., Arunachal, G., Athanasiou-Fragkouli, A., Bardhan, M., Barth, M., Bonneau, D., Brunetti-Pierri, N., Cappuccio, G., Caruana, N. J., Dominik, N., Goel, H., Helman, G., Houlden, H., Lenaers, G., Mention, K., … Horvath, R. (2023). TEFM variants impair mitochondrial transcription causing childhood-onset neurological disease. Nature communications, 14(1), 1009. https://doi.org/10.1038/s41467-023-36277-7. PMID: 36823193

 

Neuromuscular junction and animal models

Read next...

Congratulations Alexa!

Congratulations Dr. Alexa Derksen!

Congratulations to Dr. Alexa Derksen who successfully defended her PhD thesis titled "Estimating the Prevalence and Unravelling the Disease Mechanism of GNE Myopathy" on October...
Markus A. Ruegg

Graham Mainwood Lecture – Dr. Markus A. Rüegg

The University of Ottawa Éric Poulin Centre for Neuromuscular Disease (CNMD)  under the co-leadership of Dr. Hanns Lochmüller is delighted to host the 2026 Graham...
Congratulations!

PhD completion – Congratulations!

Congratulations to our two graduate students Dr. Stephen Holland and Dr. Malaichamy Sivasankar on the successful defense of their PhD dissertations!   Stephen successfully defended his PhD thesis titled...
New publications alert

New Publications Alert!

Our group has recently published two new papers with the first providing insights on the impact of GFPT1 loss in cellular models and the second...
New members post - July 2026

Meet The Lochmüller group’s Newest Members!

Our group is growing! We are excited to introduce two new members who have recently joined the Lochmüller group. Claudia Wyld Clinical Research Assistant Claudia...
Kelly and Ofosu papers (4)

New Publication: Gene-specific response to muscle specific kinase agonist antibody in the treatment of congenital myasthenic syndromes

Congenital myasthenic syndromes (CMS) are a group of rare inherited neuromuscular disorders. Although many forms of CMS appear similar clinically, the disease can be caused...